Neogen Q1 FY27 earnings: revenue up 37%, EBITDA margins expand

Mgmt Guided Margin ImprovementOrder Pipeline DisclosedPromoter Disclosed Acquisition PlansInvestor Communications View source PDF

NEOGEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

—1-day move

₹2055.00

prior close

₹2135.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-3.4-3.5-2.3-1.0——————————

Up moveDown movePending

AI summary

Neogen Chemicals Q1 FY27: Standalone revenue grew 37% YoY to INR 252.3 crore; EBITDA rose 39% to INR 48.2 crore; PAT up 37% to INR 19.4 crore. Consolidated EBITDA margins expanded 260 bps to 19.3%. Neogen Ionics revenue jumped from INR 5 crore to INR 19 crore YoY. Board approved INR 600 crore QIP raise. Dahej plant rebuild complete with trial runs underway. Interest costs up 65% YoY on higher CAPEX debt. Insurance claim receivable at INR 186 crore.

Likely market impact

Strong quarter with margin expansion and battery materials growth, partly offset by higher interest costs and pending fund raise dilution.